ImmunityBio Receives FDA RMAT Designation for ANKTIVA and CAR-NK (PD-L1 t-haNK) to Achieve Reversal of Lymphopenia in Pancreatic Cancer Patients
Culver City-based ImmunityBio, Inc., a leading immunotherapy company, has announced that the U.S. Food and Drug ...
Gene-edited lettuce: A new approach to fighting micronutrient deficiencies
A research team led by Prof. Alexander Vainstein from the Robert H. Smith Faculty of Agriculture, Food, and Environment at ...